| Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches JA Welsh, DCI Goberdhan, L O'Driscoll, EI Buzas, C Blenkiron, ... Journal of extracellular vesicles 13 (2), e12404, 2024 | 509 | 2024 |
| Exploring the use of serum‐derived small extracellular vesicles as liquid biopsy to study the induction of hepatic cytochromes P450 and organic anion transporting polypeptides AD Rodrigues, M Van Dyk, MJ Sorich, A Fahmy, Z Useckaite, LA Newman, ... Clinical Pharmacology & Therapeutics 110 (1), 248-258, 2021 | 50 | 2021 |
| Role of extracellular vesicles in the pathophysiology, diagnosis and tracking of non-alcoholic fatty liver disease LA Newman, MJ Sorich, A Rowland Journal of Clinical Medicine 9 (7), 2032, 2020 | 39 | 2020 |
| Selective isolation of liver-derived extracellular vesicles redefines performance of miRNA biomarkers for non-alcoholic fatty liver disease LA Newman, Z Useckaite, J Johnson, MJ Sorich, AM Hopkins, A Rowland Biomedicines 10 (1), 195, 2022 | 37 | 2022 |
| Circulating cell-specific extracellular vesicles as biomarkers for the diagnosis and monitoring of chronic liver diseases LA Newman, K Muller, A Rowland Cellular and Molecular Life Sciences 79 (5), 232, 2022 | 28 | 2022 |
| Importance of between and within subject variability in extracellular vesicle abundance and cargo when performing biomarker analyses LA Newman, A Fahmy, MJ Sorich, OG Best, A Rowland, Z Useckaite Cells 10 (3), 485, 2021 | 27 | 2021 |
| Role of extracellular vesicle-derived biomarkers in drug metabolism and disposition Z Useckaite, AD Rodrigues, AM Hopkins, LA Newman, J Johnson, ... Drug Metabolism and Disposition 49 (11), 961-971, 2021 | 14 | 2021 |
| Addressing MISEV guidance using targeted LC‐MS/MS: A method for the detection and quantification of extracellular vesicle‐enriched and contaminant protein markers from blood LA Newman, Z Useckaite, A Rowland Journal of Extracellular Biology 1 (9), e56, 2022 | 8 | 2022 |
| Proteomic profiling of paired human liver homogenate and tissue derived extracellular vesicles Z Useckaite, LA Newman, AM Hopkins, S Klebe, AD Colella, N Chegeni, ... Proteomics 24 (11), 2300025, 2024 | 3 | 2024 |
| Analysis of extracellular vesicle and contaminant markers in blood derivatives using multiple reaction monitoring LA Newman, Z Useckaite, T Wu, MJ Sorich, A Rowland Serum/Plasma Proteomics: Methods and Protocols, 301-320, 2023 | 3 | 2023 |
| Selective isolation of liver-derived extracellular vesicles redefines performance of miRNA biomarkers for non-alcoholic fatty liver disease. Biomedicines. 2022; 10 LA Newman, Z Useckaite, J Johnson, MJ Sorich, AM Hopkins, A Rowland s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | 2 | 2022 |
| Establishing the capacity to monitor proteins relevant to the study of drug exposure and response using liver‐derived extracellular vesicles LA Newman, Z Useckaite, T Wu, MJ Sorich, A Rowland British Journal of Clinical Pharmacology, 2024 | | 2024 |
| Study of the ketohexokinase inhibitor PF‐06835919 as a clinical cytochrome P450 3A inducer: Integrated use of oral midazolam and liquid biopsy R Qiu, K Fonseca, A Bergman, J Lin, D Tess, L Newman, A Fahmy, ... Clinical and Translational Science 17 (1), e13644, 2024 | | 2024 |
| Serum‐derived Extracellular Vesicles as Diagnostic Biomarkers for Non‐alcoholic Fatty Liver Disease L Newman The FASEB Journal 34 (S1), 1-1, 2020 | | 2020 |
